Luy Ing Yan
Director/Board Member bei MICROPORT CARDIOFLOW MEDTECH CORPORATION
Vermögen: 83 183 $ am 31.03.2024
Profil
Luy Ing Yan is currently an Executive Director at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and an Executive Director & VP-Regulatory Affairs at MicroPort CardioFlow Medtech Corp.
She completed her undergraduate and graduate degrees at Capital Medical University in 2004 and 2012, respectively.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.07.2023 | 576 137 ( 0,02% ) | 83 183 $ | 31.03.2024 |
Aktive Positionen von Luy Ing Yan
| Unternehmen | Position | Beginn |
|---|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Director/Board Member | 29.09.2020 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Director/Board Member | 29.09.2020 |
Ausbildung von Luy Ing Yan
| Capital Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
